WELL Maintained by Evercore ISI Group -- Price Target Lowered to
Evercore ISI Group maintained its 'Outperform' rating for Welltower (WELL) but lowered its price target from $260.00 to $256.00. The company's GF Value™ suggests it is 14.8% overvalued at its current price of $232.54. Welltower, a global healthcare REIT, has a GF Score™ of 84/100, indicating strong performance. Insiders have recently bought $2.41 million in shares.
How this was made
The 30-second read
Why it matters
Analyst maintains confidence but trims target, suggesting modest risk‑adjusted downside.
Market read
A small target reduction may influence short‑term trading but is unlikely to drive major market moves.
What to watch
Insider buying of $2.4 M and strong GF Score may offset valuation concerns.
Background
Welltower is the largest healthcare REIT, with a market cap of ~$168 B and a current share price of $232.54.
Ticker impact
Evercore ISI Group maintained an Outperform rating on WELL and lowered the price target to $256 on Oct 10, 2023.
Potential slight downside pressure as target falls 1.5%.
Target cut signals modest concerns; no rating downgrade, so impact likely limited.
Market effects
May prompt re‑evaluation of other healthcare REITs as analysts tighten valuations.
Limited to U.S. REIT market; no broader regional effect.
Minimal global impact beyond U.S. healthcare real estate sector.
Counterpoint
The price target cut could be an over‑reaction; the Outperform rating still supports upside.
Key entities
- CompanyWelltower Inc.
Healthcare real estate investment trust.
- Research FirmEvercore ISI Group
Provides the rating and price target.



